Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991
Dissection of the Extracranial Vertebral Artery:Report of Four Cases and Review of the Literature
JNNP 54:863-869, Hinse,P.,et al, 1991
Percutaneous Decompression for Femoral Neuropathy Secondary to Heparin-Induced Retroperitoneal Hematoma:Case Rpt & Review
Am Surg 57:706-710, Merrick,H.W.,et al, 1991
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991
Clinicopath Conf
Thrombotic Thrombocytopenic Purpura, Case 30-1991, NEJM 325:265-273991., , 1991
Clinicopath Conf
CA of Lung, DIC, Marantic Endocarditis, Multiple CVA's, Case 36-1991, NEJM 325:714-726., , 1991
Heparin Treatment in Sinus Venous Thrombosis
Lancet 338:597-600, Einhaupl,K.M.,et al, 1991
Prognostic Parameters in Spontaneous Intracerebral Hematomas with Special Reference to Anticoagulant Treatment
Stroke 22:571-576, Radberg,J.A.,et al, 1991
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991
The European Stroke Prevention Study:Results According to Sex
Neurol 41:1189-1192, Sivenius,J.,et al, 1991
Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991
Antiphospholipid Antibodies in Cerebral Ischemia
Stroke 22:750-753, Montalban,J.,et al, 1991
Cardiac Imaging in Stroke
Stroke 22:1206-1211, Tegeler,C.H.&Downes,T.B., 1991
Oral Anticoagulant Drugs
NEJM 324:1865-1875, Hirsh,J., 1991
Early Heparin Therapy in Patients with Spontaneous Intracerebral Haemorrhage
JNNP 54:466-467, Boeer,A.,et al, 1991
Atrial Fibrillation as a Risk Factor for Deep Venous Thrombosis and Pulmonary Emboli in Stroke Patients
Stroke 22:760-762, Noel,P.,et al, 1991
Platelet-Activating Factor in Stroke and Brain Injury
Ann Neurol 30:117-129, Lindsberg,P.J.,et al, 1991
Mononeuropathy Multiplex Complicating Idiopathic Thrombocytopenic Purpura
Neurol 41:1517-1518, Greenberg,M.K.&Sonoda,T., 1991
Stroke Prevention in Women:role of Aspirin Versus Ticlopidine
Am J Med 91:288-292, Hershey,L.A., 1991
Ultrasound Findings in Spontaneous Carotid Artery Dissection, The Value of Duplex Sonography
Arch Neurol 48:1057-1063, Sturzenegger,M., 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Current Management of Amaurosis Fugax
The Amaurosis Fugax Study Group, Stroke 21:201-2081990., , 1990
Ticlopidine, A New Antithrombotic Drug:But Is It Better than Aspirin for Longterm Use?
JNNP 53:185-187, Warlow,C., 1990
European Stroke Prevention Study
ESPS Group, Stroke 21:1122-11301990., , 1990
Left Ventricular Thrombosis and Stroke Following Myocardial Infarction
Editorial, Lancet 335:759-7601990., , 1990
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
NEJM 323:148-152, Smith,P.,et al, 1990
Intracerebral Hematomas During Anticoagulant Treatment
Stroke 21:726-730, Franke,C.L.,et al, 1990
Anticoagulation:Is There Still a Role in Atherothrombotic Stroke
Stroke 21:820-824, Estol,C.J.&Pessin,M.S., 1990
Cerebrovascular and Neurologic Disease Associated with Antiphospholipid Antibodies:48 Cases
Neurol 40:1181-1189, Levine,S.R.,et al, 1990
Prosthetic Valve Endocarditis 1976-1987, Antibiotics, Anticoagulation, and Stroke
Stroke 21:993-999, Davenport,H.&Hart,R.G., 1990
Cerebral Venous Thrombosis in Systemic Lupus Erythematosus
Stroke 21:1226-1231, Vidailhet,M.,et al, 1990
Stroke in Pediatric Acquired Immunodeficiency Syndrome
Ann Neurol 28:303-311, Park,Y.D.,et al, 1990
HTLV-I-Associated Myelopathy
NEJM 323:552, Engel,W.K.,et al, 1990
Stroke in Infective Endocarditis
Stroke 21:695-700, Hart,R.G.,et al, 1990
Cerebrovascular Disease in AIDS:A Case-Control Study
AIDS 4:239-244, Berger,J.R.,et al, 1990
Thromboembolic Complications in Atrial Fibrillation
Stroke 21:4-13, Petersen,P., 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Anticardiolipin Antibodies in Sneddon's Syndrome
Neurol 40:464-467, Kalashnikova,L.A.,et al, 1990
Valproic Acid-Induced Cytopenias:Evidence for a Dose-Related Suppression of Hematopoiesis
J Pediatr 117:495-497, Watts,R.G.,et al, 1990
Low-Dose Aspirin for Migraine Prophylaxis
JAMA 264:1711-1713, 17211990., Burning,J.E.,et al, 1990
Management Dilemmas in Carotid Artery Disease
Patient Care 24:14-46, Adams,H.P.,et al, 1990
Aspirin and Stroke
Arch Neurol 47:1353-1354, Buring,J.E.,et al, 1990
The Physician's Health Study, A Neurologist's Concern
Arch Neurol 47:1352-1354, Jonas,S., 1990
Mechanism of Stroke in Patients Taking Aspirin
Neurol 40:1682-1685, Chimowitz,M.I.,et al, 1990